Buchmeier MJ, de la Torre JC, Peters CJ: Arenaviridae: the viruses and their replication. In Fields Virology. Volume 2. Edited by: Knipe DM, Howley PM. Lippincott Williams & Wilkins, a Wolters Klumer Business; 2007:1791–1828.
Google Scholar
Barton LL, Hyndman NJ: Lymphocytic choriomeningitis virus: reemerging central nervous system pathogen.
Pediatrics 2000, 105:E35.
Article
CAS
PubMed
Google Scholar
Barton LL, Mets MB, Beauchamp CL: Lymphocytic choriomeningitis virus: emerging fetal teratogen.
Am J Obstet Gynecol 2002, 187:1715–1716.
Article
PubMed
Google Scholar
Bonthius DJ, Wright R, Tseng B, Barton L, Marco E, Karacay B, Larsen PD: Congenital lymphocytic choriomeningitis virus infection: spectrum of disease.
Ann Neurol 2007, 62:347–355.
Article
PubMed
Google Scholar
Gonzalez JP, Emonet S, de Lamballerie X, Charrel R: Arenaviruses.
Curr Top Microbiol Immunol 2007, 315:253–288.
Article
CAS
PubMed
Google Scholar
Maiztegui JI: Clinical and epidemiological patterns of Argentine haemorrhagic fever.
Bull World Health Organ 1975, 52:567–575.
CAS
PubMed
Google Scholar
McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES: A prospective study of the epidemiology and ecology of Lassa fever.
J Infect Dis 1987, 155:437–444.
CAS
PubMed
Google Scholar
Maiztegui JI, McKee KT Jr, Barrera Oro JG, Harrison LH, Gibbs PH, Feuillade MR, Enria DA, Briggiler AM, Levis SC, Ambrosio AM, Halsey NA, Peters CJ: Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group.
J Infect Dis 1998, 177:277–283.
Article
CAS
PubMed
Google Scholar
Enria DA, Briggiler AM, Levis S, Vallejos D, Maiztegui JI, Canonico PG: Tolerance and antiviral effect of ribavirin in patients with Argentine hemorrhagic fever.
Antiviral Res 1987, 7:353–359.
Article
CAS
PubMed
Google Scholar
McKee KT Jr, Huggins JW, Trahan CJ, Mahlandt BG: Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever.
Antimicrob Agents Chemother 1988, 32:1304–1309.
CAS
PubMed
Google Scholar
Botten J, Alexander J, Pasquetto V, Sidney J, Barrowman P, Ting J, Peters B, Southwood S, Stewart B, Rodriguez-Carreno MP, Mothe B, Whitton JL, Sette A, Buchmeier MJ: Identification of protective Lassa virus epitopes that are restricted by HLA-A2.
J Virol 2006, 80:8351–8361.
Article
CAS
PubMed
Google Scholar
Botten J, Whitton JL, Barrowman P, Sidney J, Whitmire JK, Alexander J, Ting JP, Bui HH, Sette A, Buchmeier MJ: HLA-A2-Restricted Protection against Lethal Lymphocytic Choriomeningitis.
J Virol 2007, 81:2307–2317.
Article
CAS
PubMed
Google Scholar
Kotturi MF, Peters B, Buendia-Laysa F Jr, Sidney J, Oseroff C, Botten J, Grey H, Buchmeier MJ, Sette A: The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus.
J Virol 2007, 81:4928–4940.
Article
CAS
PubMed
Google Scholar
Kotturi MF, Botten J, Sidney J, Bui HH, Giancola L, Maybeno M, Babin J, Oseroff C, Pasquetto V, Greenbaum JA, Peters B, Ting J, Do D, Vang L, Alexander J, Grey H, Buchmeier MJ, Sette A: A multivalent and cross-protective vaccine strategy against arenaviruses associated with human disease.
PLoS Pathog 2009, 5:e1000695.
Article
PubMed
Google Scholar
Auperin DD, Esposito JJ, Lange JV, Bauer SP, Knight J, Sasso DR, McCormick JB: Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection.
Virus Res 1988, 9:233–248.
Article
CAS
PubMed
Google Scholar
Morrison HG, Bauer SP, Lange JV, Esposito JJ, McCormick JB, Auperin DD: Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus.
Virology 1989, 171:179–188.
Article
CAS
PubMed
Google Scholar
Fisher-Hoch SP, Hutwagner L, Brown B, McCormick JB: Effective vaccine for lassa fever.
J Virol 2000, 74:6777–6783.
Article
CAS
PubMed
Google Scholar
Clegg JC: Current progress towards vaccines for arenavirus-caused diseases.
Vaccine 1992, 10:89–95.
Article
CAS
PubMed
Google Scholar
Fisher-Hoch SP, McCormick JB: Towards a human Lassa fever vaccine.
Rev Med Virol 2001, 11:331–341.
Article
CAS
PubMed
Google Scholar
McCormick JB: Clinical, epidemiologic, and therapeutic aspects of Lassa fever.
Med Microbiol Immunol 1986, 175:153–155.
Article
CAS
PubMed
Google Scholar
Maiztegui JI, Fernandez NJ, de Damilano AJ: Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome.
Lancet 1979, 2:1216–1217.
Article
CAS
PubMed
Google Scholar
McKee KT Jr, Oro JG, Kuehne AI, Spisso JA, Mahlandt BG: Safety and immunogenicity of a live-attenuated Junin (Argentine hemorrhagic fever) vaccine in rhesus macaques.
Am J Trop Med Hyg 1993, 48:403–411.
PubMed
Google Scholar
Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP: CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes.
Nature 2003, 421:852–856.
Article
CAS
PubMed
Google Scholar
Battegay M, Moskophidis D, Rahemtulla A, Hengartner H, Mak TW, Zinkernagel RM: Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice.
J Virol 1994, 68:4700–4704.
CAS
PubMed
Google Scholar
Matloubian M, Concepcion RJ, Ahmed R: CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
J Virol 1994, 68:8056–8063.
CAS
PubMed
Google Scholar
Elsaesser H, Sauer K, Brooks DG: IL-21 is required to control chronic viral infection.
Science 2009, 324:1569–1572.
Article
CAS
PubMed
Google Scholar
Yi JS, Du M, Zajac AJ: A vital role for interleukin-21 in the control of a chronic viral infection.
Science 2009, 324:1572–1576.
Article
CAS
PubMed
Google Scholar
Frohlich A, Kisielow J, Schmitz I, Freigang S, Shamshiev AT, Weber J, Marsland BJ, Oxenius A, Kopf M: IL-21R on T cells is critical for sustained functionality and control of chronic viral infection.
Science 2009, 324:1576–1580.
Article
PubMed
Google Scholar
Jellison ER, Kim SK, Welsh RM: Cutting edge: MHC class II-restricted killing in vivo during viral infection.
J Immunol 2005, 174:614–618.
CAS
PubMed
Google Scholar
Southwood S, Sidney J, Kondo A, del Guercio MF, Appella E, Hoffman S, Kubo RT, Chesnut RW, Grey HM, Sette A: Several common HLA-DR types share largely overlapping peptide binding repertoires.
J Immunol 1998, 160:3363–3373.
CAS
PubMed
Google Scholar
Calvo-Calle JM, Strug I, Nastke MD, Baker SP, Stern LJ: Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection.
PLoS Pathog 2007, 3:1511–1529.
Article
CAS
PubMed
Google Scholar
Altmann DM, Douek DC, Frater AJ, Hetherington CM, Inoko H, Elliott JI: The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4.
J Exp Med 1995, 181:867–875.
Article
CAS
PubMed
Google Scholar
Darrah PA, Patel DT, de Luca PM, Lindsay RW, Davey DF, Flynn BJ, Hoff ST, Andersen P, Reed SG, Morris SL, Roederer M, Seder RA: Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major.
Nat Med 2007, 13:843–850.
Article
CAS
PubMed
Google Scholar
Ciuffreda D, Comte D, Cavassini M, Giostra E, Buhler L, Perruchoud M, Heim MH, Battegay M, Genne D, Mulhaupt B, Malinverni R, Oneta C, Bernasconi E, Monnat M, Cerny A, Chuard C, Borovicka J, Mentha G, Pascual M, Gonvers JJ, Pantaleo G, Dutoit V: Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.
Eur J Immunol 2008, 38:2665–2677.
Article
CAS
PubMed
Google Scholar
Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR: Help for cytotoxic-T-cell responses is mediated by CD40 signalling.
Nature 1998, 393:478–480.
Article
CAS
PubMed
Google Scholar
Ridge JP, Di Rosa F, Matzinger P: A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.
Nature 1998, 393:474–478.
Article
CAS
PubMed
Google Scholar
Schoenberger SP, Toes RE, Voort EI, Offringa R, Melief CJ: T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.
Nature 1998, 393:480–483.
Article
CAS
PubMed
Google Scholar
Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ: Molecular mechanism and function of CD40/CD40L engagement in the immune system.
Immunol Rev 2009, 229:152–172.
Article
CAS
PubMed
Google Scholar
Bui HH, Sidney J, Dinh K, Southwood S, Newman MJ, Sette A: Predicting population coverage of T-cell epitope-based diagnostics and vaccines.
BMC Bioinformatics 2006, 7:153.
Article
PubMed
Google Scholar
Meyer D, Singe RM, Mack SJ, Lancaster A, Nelson MP, Erlich H, Frenandez-Vina M, Thomson G: Single Locus Polymorphism of Classical HLA Genes. In Immunobiology of the Human MHC: Proceedings of the 13th International Histocompatibility Workshop and Conference; Seattle, WA. Edited by: Hansen JA. IHWG Press; 2007:653–704.
Google Scholar
ter Meulen J, Badusche M, Kuhnt K, Doetze A, Satoguina J, Marti T, Loeliger C, Koulemou K, Koivogui L, Schmitz H, Fleischer B, Hoerauf A: Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein.
J Virol 2000, 74:2186–2192.
Article
CAS
PubMed
Google Scholar
Meulen J, Badusche M, Satoguina J, Strecker T, Lenz O, Loeliger C, Sakho M, Koulemou K, Koivogui L, Hoerauf A: Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones.
Virology 2004, 321:134–143.
Article
CAS
PubMed
Google Scholar
Geluk A, Taneja V, van Meijgaarden KE, Zanelli E, Abou-Zeid C, Thole JE, de Vries RR, David CS, Ottenhoff TH: Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice.
Proc Natl Acad Sci USA 1998, 95:10797–10802.
Article
CAS
PubMed
Google Scholar
Mangalam AK, Rajagopalan G, Taneja V, David CS: HLA class II transgenic mice mimic human inflammatory diseases.
Adv Immunol 2008, 97:65–147.
Article
CAS
PubMed
Google Scholar
Bogaert D, Hermans PW, Adrian PV, Rumke HC, de Groot R: Pneumococcal vaccines: an update on current strategies.
Vaccine 2004, 22:2209–2220.
Article
CAS
PubMed
Google Scholar
Bryan JT: Developing an HPV vaccine to prevent cervical cancer and genital warts.
Vaccine 2007, 25:3001–3006.
Article
CAS
PubMed
Google Scholar
Botten JW, Kotturi MF: Adaptive immunity to Lymphocyctic choriomeningitis virus: new insights into antigenic determinants.
Future Virology 2007, 2:495–508.
Article
CAS
Google Scholar
Homann D, Lewicki H, Brooks D, Eberlein J, Mallet-Designe V, Teyton L, Oldstone MB: Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class II.
Virology 2007, 363:113–123.
Article
CAS
PubMed
Google Scholar
Mothe BR, Stewart BS, Oseroff C, Bui HH, Stogiera S, Garcia Z, Dow C, Rodriguez-Carreno MP, Kotturi M, Pasquetto V, Botten J, Crotty S, Janssen E, Buchmeier MJ, Sette A: Chronic lymphocytic choriomeningitis virus infection actively down-regulates CD4+ T cell responses directed against a broad range of epitopes.
J Immunol 2007, 179:1058–1067.
CAS
PubMed
Google Scholar
Dow C, Oseroff C, Peters B, Nance-Sotelo C, Sidney J, Buchmeier M, Sette A, Mothe BR: Lymphocytic choriomeningitis virus infection yields overlapping CD4+ and CD8+ T-cell responses.
J Virol 2008, 82:11734–11741.
Article
CAS
PubMed
Google Scholar
Crowe SR, Miller SC, Brown DM, Adams PS, Dutton RW, Harmsen AG, Lund FE, Randall TD, Swain SL, Woodland DL: Uneven distribution of MHC class II epitopes within the influenza virus.
Vaccine 2006, 24:457–467.
Article
CAS
PubMed
Google Scholar
Harari A, Dutoit V, Cellerai C, Bart PA, Du Pasquier RA, Pantaleo G: Functional signatures of protective antiviral T-cell immunity in human virus infections.
Immunol Rev 2006, 211:236–254.
Article
CAS
PubMed
Google Scholar
Betts MR, Nason MC, West SM, de Rosa SC, Migueles SA, Abraham J, Lederman MM, Benito JM, Goepfert PA, Connors M, Roederer M, Koup RA: HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.
Blood 2006, 107:4781–4789.
Article
CAS
PubMed
Google Scholar
Almeida JR, Price DA, Papagno L, Arkoub ZA, Sauce D, Bornstein E, Asher TE, Samri A, Schnuriger A, Theodorou I, Costagliola D, Rouzioux C, Agut H, Marcelin AG, Douek D, Autran B, Appay V: Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover.
J Exp Med 2007, 204:2473–2485.
Article
CAS
PubMed
Google Scholar
Duvall MG, Precopio ML, Ambrozak DA, Jaye A, McMichael AJ, Whittle HC, Roederer M, Rowland-Jones SL, Koup RA: Polyfunctional T cell responses are a hallmark of HIV-2 infection.
Eur J Immunol 2008, 38:350–363.
Article
CAS
PubMed
Google Scholar
Sidney J, Southwood S, Oseroff C, Guercio MFD, Sette A, Grey H: Measurement of MHC/peptide interactions by gel filtration. In Current Protocols in Immunology I. Edited by: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. New York: John Wiley & Sons; 1998:18.13.11–18.13.19.
Google Scholar
Biodefense and Emerging Infections Research Resources Repository [http://www.beiresources.org]
Moutaftsi M, Bui HH, Peters B, Sidney J, Salek-Ardakani S, Oseroff C, Pasquetto V, Crotty S, Croft M, Lefkowitz EJ, Grey H, Sette A: Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses.
J Immunol 2007, 178:6814–6820.
CAS
PubMed
Google Scholar